Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia

NCT00281892

Conditions
Anemia, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg Augsburg, Germany
  • Onkologische Schwerpunktpraxis und Tagesklinik Dres Bad Soden, Germany
  • Internistische Gemeinschaftspraxis - Berlin Berlin, Germany
  • Charite - Campus Charite Mitte Berlin, Germany
View all 46 locations
View Trial Details
Completed

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia

NCT00275015

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Humaine - Clinic Bad Saarow, Germany
  • Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany
View all 53 locations
View Trial Details
Completed

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

NCT01263704

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Haemek Medical Center; Hematology Department Afula, Israel
  • Soroka Medical Center; Hematology Deptartment Beersheba, Israel
  • Rambam Medical Center; Heamatology & Bone Marrow Transplantation Haifa, Israel
  • Bnei-Zion Medical Center; Hematology Dept Haifa, Israel
View Trial Details
Completed

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00963274

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +23 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions
Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)

NCT01030536

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Indianapolis, Indiana, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Las Vegas, Nevada, United States
View Trial Details

Related conditions